Almac has opened analytical laboratories at its new 240,000-sq.-ft. North American Headquarters in Souderton, PA. The move is part of the Almac Group’s integrated services solutions strategy.

The site’s analytical labs complement existing facilities in the UK. The lab provides support for clinical packaging operations as well as stand-alone analytical services. The labs are equipped with the latest equipment, including HPLC, UPLC, GC, UV, IR, DSC, KF and others. The new group will also offer Polymorph and Salt Screening and Solid Form Development, according to an Almac statement.

Almac has installed the latest bathless dissolution apparatus for rapid and efficient comparative dissolution studies. Installation of the newest Waters H-Class HPLC/UPLC systems provides maximum flexibility for developing, validating and running assay, dissolution and stability methods. Large capacity stability chambers provide required ICH stability conditions in the new labs.

The new analytical facility complements Almac’s specialty capabilities, including biocatalysis, radiolabeling, and peptide and protein synthesis. These services are all part of Almac’s comprehensive Drug Development Services, including API and drug product development and GMP manufacture.